Todd Bazemore
Präsident bei KALA BIO, INC.
Vermögen: 30 263 $ am 30.04.2024
Aktive Positionen von Todd Bazemore
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| KALA BIO, INC. | Geschäftsführer | 20.11.2017 | - |
| Präsident | 16.12.2021 | - | |
| PULMATRIX, INC. | Direktor/Vorstandsmitglied | 01.10.2020 | - |
| Independent Dir/Board Member | 01.10.2020 | - |
Karriereverlauf von Todd Bazemore
Ehemalige bekannte Positionen von Todd Bazemore
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SANTHERA PHARMACEUTICALS HOLDING AG | Geschäftsführer | 01.09.2016 | 01.11.2017 |
Santhera Pharmaceuticals (USA), Inc.
 Santhera Pharmaceuticals (USA), Inc. Pharmaceuticals: MajorHealth Technology Santhera Pharmaceuticals (USA), Inc. engages in the provision of regulatory and medical services. The company is headquartered in Burlington, MA. | Geschäftsführer | 01.09.2016 | 01.11.2017 |
| DYAX CORP. | Corporate Officer/Principal | 16.04.2014 | 22.01.2016 |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Corporate Officer/Principal | 01.12.2010 | 01.09.2013 |
| Vertrieb & Marketing | 01.12.2009 | 01.12.2010 |
Ausbildung von Todd Bazemore
| University of Massachusetts Lowell | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
| Schweiz | 2 |
Operativ
| Chief Operating Officer | 3 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 7 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| SANTHERA PHARMACEUTICALS HOLDING AG | Health Technology |
| KALA BIO, INC. | Health Technology |
| PULMATRIX, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Dyax Corp.
 Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
Santhera Pharmaceuticals (USA), Inc.
Santhera Pharmaceuticals (USA), Inc. Pharmaceuticals: MajorHealth Technology Santhera Pharmaceuticals (USA), Inc. engages in the provision of regulatory and medical services. The company is headquartered in Burlington, MA. | Health Technology |
- Börse
- Insiders
- Todd Bazemore
- Erfahrung
